Despite clinical trial evidence and recommendations that certain older breast cancer patients can forego radiation therapy after lumpectomy, most older patients continue to receive radiation therapy, according to a new study.
The FDA has approved the first single-dose intravenous NK1 receptor antagonist, fosaprepitant dimeglumine (Emend), for the treatment of nausea and vomiting that can accompany the use of moderately and highly emetogenic chemotherapy.
Women younger than 40 may be more likely to frequent indoor tanning, and those who do are between two and six times more likely to develop melanoma, according to a new study.
Nanoliposomal irinotecan combined with fluorouracil/leucovorin improved overall survival in metastatic pancreatic cancer patients who have already been treated with gemcitabine.
More than 15% of men and women over the age of 65 may have received breast or prostate cancer screening not recommended by current guidelines.
An observational study found that adjuvant chemotherapy improves overall survival in patients with locally advanced bladder cancer.
Everolimus improved progression-free survival by 6 to 8 months compared with placebo in patients with advanced neuroendocrine tumors of the gastrointestinal tract.
Adolescent girls who live in predominantly Hispanic and high poverty communities are more likely to have had at least one HPV vaccine dose compared to girls in low poverty communities and those with different ethnic make up.
Mice fed sugar at levels comparable to those in a typical Western diet had greater tumor growth and metastasis compared to mice fed a starch-based, no-sugar diet.
A published statement by ASCO lays out concerns about the ways in which clinical pathways, a system designed to improve the quality of care cancer patients receive, are being utilized within the US healthcare system.